Respiratory Diseases

FDA approves Fragmin- an anticoagulant for children   The FDA today approved Fragmin for the treatment of blood clots. Pfizer’s candidate Fragmin which was earlier approved for the treatment of only adults suffering from a fatal disease called VTE, which can include deep vein thrombosis (blood clot in the deep veins of the leg) and pulmonary embolism (blood clot in the lungs), has now been approved to be used for children. This approval will benefit many children who are fighting cancer and struggling with serious conditions like VTE. Symbicort reduces the rate of Asthma attack The trials conducted by AstraZeneca for its novel Symbicort Turbuhaler (bude...